Research
Hormonal
Orlistat improves glycemic control and reduces the need for diabetes medication in patients with Type 2 Diabetes, independent of weight loss alone.
If you have Type 2 Diabetes, Orlistat can help lower your blood sugar and HbA1c levels more than diet alone, potentially allowing you to reduce your diabetes medication dosage. This benefit appears to go beyond just the weight loss itself.
GoodSupportsHIGH confidence
Orlistat was effective in reducing weight and improving glycemic control in patients with type 2 diabetes... This suggests that orlistat may have an added effect above that of diet alone in improving glycemic control.
Why this rating
Based on a randomized, double-blind, placebo-controlled trial (57 weeks).
Source
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Amy Sheehan et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2000
DOI 10.1592/phco.20.4.270.34882
narrative_reviewCited 554×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Orlistat reduces the absorption of fat-soluble vitamins (specifically D and E) and beta-carotene, necessitating daily multivitamin supplementation taken 2 hours before or after the drug.Strong
- Orlistat (120 mg three times daily with meals) promotes greater weight loss and weight maintenance compared to diet alone in obese adults, primarily by inhibiting gastric and pancreatic lipases to reduce dietary fat absorption.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →